Factdock Insights

Sanarwa na hukuma da ayyukan da ake kan yi, ana tattarawa kowace rana daga cibiyoyin da suka fara wallafa su — kuma ana rubuta su a harsuna 38 domin masu bincike, likitocin dabbobi, manazarta da ƙwararru.

Raba
Kai tsaye · cibiyoyi na farko 135 ana sa ido kowace ranaAn sabunta · 2026-09-20 22:10 UTC
Babban labarin yau

Specialised Therapeutics Ta Fadada Haɗin gwiwa da Incyte don Haɗa Ruxolitinib Cream (Opzelura®) a Ostiraliya

SINGAPORE, Satumba 20, 2026 /PRNewswire/ -- Kamfanin biopharmaceutical mai zaman kansa Specialised Therapeutics (ST) a yau ya sanar da fadada haɗin gwiwarsa da Incyte Biosciences International, wani reshe na Incyte (NASDAQ: INCY), don kasuwanci, rarrabawa, da rajista...

Makamashi da yanayiAyyukan da ake kan yi da ci gabaPR Newswire (Health)
Karanta tushen

Fannoni tara, ana sabuntawa kowace rana. Buɗe wani fanni don ganin sabbin bayanan hukuma da sabbin ayyukan da ake kan yi a cikinsa.

Mallakar hankali da haƙƙin ƙirƙiraAyyukan da ake kan yi da ci gabaPR Newswire (Venture Capital)US

S2S China Ta Sanar da Masu Fina-Finai na 2026, Kungiyoyi Goma Masu Fice Sun Shirya Gabatarwa ga Masu Zuba Jari na Duniya a Jami'ar Westlake

SHANGHAI, Satumba 20, 2026 /PRNewswire/ -- Taron farko na S2S China Symposium ya sanar da masu shiga gasar shirin na 2026. Wanda RA Capital Management da Qiming Venture Partners suka shirya tare, S2S China shine babi na China na Science2Startup, taron gayyata kawai wanda ke haɗa manyan...

Karanta tushen

Sabbin abubuwa a kowane fanni

Karanta kowane bayani da yarenka

Wannan shafi yana nuna sabbin abubuwa uku ne kawai a kowane fanni. Mambobi na ganin kowane bayani a cikin fannin, a harsuna 109, tare da injinan bincike da ke aiki a kansu.

Karanta duka kan $29

Babu buƙatar shigarwa daga kantin manhajoji. Ana iya soke shi kowane lokaci.

Kowane abu yana da haɗi zuwa cibiyar da ta wallafa shi. Ba a sake rubuta komai ba tare da tushensa ba.